Bioethics from a pragmatic perspective: ethical issues in biopharmaceuticals

  • Michael A. Fournel


In recent times competitive, commercial and fiscal pressures have introduced new and challenging issues for the pharmaceutical industry. This essay identifies some of these issues and proposes mechanisms for their resolution. This overview is not intended to serve as a comprehensive assessment, but rather as an introduction to and call for utilization of bioethics as a tool in the resolution of practical issues that otherwise could limit the development and introduction of important therapeutic entities into the clinic.

Author Biography

Michael A. Fournel

Senior Vice-President of Research and Development for Bayer HealthCare's Biological Products Division. Bayer HealthCare.

Keywords pharmaceutical industry, ethical challenges, social behavior, drug development, safety.
How to Cite
Fournel, M. (2005). Bioethics from a pragmatic perspective: ethical issues in biopharmaceuticals. Acta Bioethica, 11(1). Retrieved from